1. Home
  2. CMMB vs AWH Comparison

CMMB vs AWH Comparison

Compare CMMB & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMMB
  • AWH
  • Stock Information
  • Founded
  • CMMB 2004
  • AWH 1993
  • Country
  • CMMB Israel
  • AWH United States
  • Employees
  • CMMB N/A
  • AWH N/A
  • Industry
  • CMMB Biotechnology: Pharmaceutical Preparations
  • AWH Medical/Dental Instruments
  • Sector
  • CMMB Health Care
  • AWH Health Care
  • Exchange
  • CMMB Nasdaq
  • AWH Nasdaq
  • Market Cap
  • CMMB N/A
  • AWH 12.8M
  • IPO Year
  • CMMB N/A
  • AWH N/A
  • Fundamental
  • Price
  • CMMB $1.68
  • AWH $0.77
  • Analyst Decision
  • CMMB Strong Buy
  • AWH Buy
  • Analyst Count
  • CMMB 3
  • AWH 2
  • Target Price
  • CMMB $7.33
  • AWH $4.40
  • AVG Volume (30 Days)
  • CMMB 87.4K
  • AWH 82.2K
  • Earning Date
  • CMMB 11-14-2024
  • AWH 11-14-2024
  • Dividend Yield
  • CMMB N/A
  • AWH N/A
  • EPS Growth
  • CMMB N/A
  • AWH N/A
  • EPS
  • CMMB N/A
  • AWH N/A
  • Revenue
  • CMMB N/A
  • AWH $8,963,000.00
  • Revenue This Year
  • CMMB N/A
  • AWH $11.87
  • Revenue Next Year
  • CMMB N/A
  • AWH $79.10
  • P/E Ratio
  • CMMB N/A
  • AWH N/A
  • Revenue Growth
  • CMMB N/A
  • AWH N/A
  • 52 Week Low
  • CMMB $0.45
  • AWH $0.67
  • 52 Week High
  • CMMB $2.55
  • AWH $5.65
  • Technical
  • Relative Strength Index (RSI)
  • CMMB 52.44
  • AWH 48.00
  • Support Level
  • CMMB $1.53
  • AWH $0.68
  • Resistance Level
  • CMMB $1.71
  • AWH $0.85
  • Average True Range (ATR)
  • CMMB 0.11
  • AWH 0.08
  • MACD
  • CMMB -0.01
  • AWH 0.00
  • Stochastic Oscillator
  • CMMB 39.47
  • AWH 42.86

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Share on Social Networks: